comparemela.com

Latest Breaking News On - Garvin institute - Page 1 : comparemela.com

Ten positive tests and counting: The mystery of why some people just keep catching COVID

Ten positive tests and counting: The mystery of why some people just keep catching COVID
abc.net.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abc.net.au Daily Mail and Mail on Sunday newspapers.

$5 million in new funding announced for cancer researchers

$5 million in new funding announced for cancer researchers
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Garvan Institute highlights crucial research in Disease Dilemmas campaign

March 12, 2021 10:33 The Garvan Institute of Medical Research is asking Australians uncomfortable questions about the causes they choose to donate to, in a new campaign featuring real people living with diseases. With thousands of disease-related charities in Australia, The Garvin Institute engaged BWM Dentsu to launch its first nationwide campaign, highlighting how the institute can help a whole range of people with different conditions through its genomics research. The ‘Disease Dilemmas’ campaign presents two different Australians, each with a chronic disease, and asks the viewer to decide who they’d donate to. Across several different TV and static assets, a young mother with pancreatic cancer is placed next to a retired musician with Parkinson’s disease. In another spot, a teacher with a kidney condition stands next to a student with immune disease.

Breakthroughs for Type 1 diabetes

NanoString Technologies : Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference

Message : Required fields Data in Twenty-One Poster and Oral Presentations Highlight use of GeoMx Digital Spatial Profiler and the Spatial Molecular Imager Platform for Discovery and Translational Applications NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of a Technology Access Program (TAP) for the Spatial Molecular Imager. Under the program, a customer can submit tissue samples to NanoString to be analyzed using the 1000-plex RNA panel and receive a complete data package. Researchers interested in participating in NanoString’s Technology Access Program should contact the company at TAP@nanostring.com.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.